Pharmaceutical manufacturer scaling international licensing and SAP operations
DEVA is a Turkish pharmaceutical producer with 650+ products across 14 therapeutic areas, operating manufacturing facilities in two locations with 620 million unit annual capacity. The tech stack is enterprise-heavy (SAP CO/MM/FI, MES, LIMS, SCADA) and hiring is concentrated in regulatory and quality roles—reflecting a company managing high-compliance manufacturing and pushing into international regulatory filings. Active projects center on CTD preparation, licensing variation applications, and SAP SD restructuring, suggesting a strategic shift toward formalized international market entry rather than domestic-only production.
Notable leadership hires: Quality Assurance Chief
DEVA Holding, founded in 1958, is one of Turkey's largest integrated pharmaceutical manufacturers. The company produces human pharmaceuticals, active ingredients, veterinary products, and medical vials across therapeutic areas including oncology, cardiology, respiratory, and ophthalmology. Manufacturing occurs at two sites (Çerkezköy and Kartepe) with EU GMP and US FDA-approved facilities; the product portfolio holds regulatory approvals in over 80 countries including the United States, Germany, and Switzerland. Operationally, the company runs a complex SAP environment (CO, MM, FI modules) with manufacturing systems (MES, LIMS, SCADA) and is actively restructuring sales processes and integrating third-party systems to support international expansion.
SAP (CO, MM, FI modules), MES, LIMS, SCADA, Microsoft Office suite, EDI, Active Directory, Teams, Windows Server, Adobe Creative Suite, VMware, and DNS/DHCP infrastructure.
DEVA holds product licenses in over 80 countries including the United States, Germany, Switzerland, and maintains active projects for international market licensing and CTD regulatory filings.
Other companies in the same industry, closest in size